Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Future Oncology (London, England)|June 14, 2025
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK studyFranco Antonio, Luisa Carbognin, Ida Paris, et al.
Cancers|October 14, 2022
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-MakingFrancesco Pavese, Ettore Domenico Capoluongo, Margherita Muratore, et al.
The Lancet. Oncology|January 27, 2022
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trialMin Yan, Quchang Ouyang, Tao Sun, et al.
Cancers|December 30, 2025
Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary CohortElena Jane Mason, Alba Di Leone, Beatrice Carnassale, et al.
NPJ Breast Cancer|February 5, 2025
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapyLuca Mastrantoni, Giovanna Garufi, Giulia Giordano, et al.
Life (Basel, Switzerland)|April 26, 2025
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes TumorsFlavia De Lauretis, Alejandro Martin Sanchez, Cristina Accetta, et al.
Science China. Life Sciences|May 17, 2022
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancerChang Gong, Ziliang Cheng, Yaping Yang, et al.
Breast Care (Basel, Switzerland)|July 1, 2026
Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R TrialRosa Di Micco, Lorenzo Scardina, Edoardo Botteri, et al.
JNCI Cancer Spectrum|October 15, 2025
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancerAlessandra Fabi, Antonio Franco, Laura Cortesi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 13, 2025
Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors)Alejandro M Sanchez, Flavia De Lauretis, Angela Bucaro, et al.
Pageof 17